<qa>  What is the ERYTHROCYTE COMT ACTIVITY in PARKINEFFECT OF TWO MULTIPLE-DOSE REGIMENS OF BIA 3-202 ON THE PHARMACOKINETICS AND MOTOR RESPONSE OF LEVODOPA, AND ON THE ERYTHROCYTE COMT ACTIVITY IN PARKINSONS DISEASE PATIENTS: 